In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency.
about
Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiencyBiochemical and electrophoretic studies of erythrocyte pyridoxine kinase in white and black AmericansAssessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern IndonesiaMolecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-).Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes.Unstable variant of NADH methemoglobin reductase in Puerto Ricans with hereditary methemoglobinemiaDefective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase.Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.Genetic variants of glucose 6-phosphate dehydrogenase from human erythrocytes: unique properties of the A - variant isolated from "deficient" cells.Chemical toxicity of red cells.Red cell uridine monophosphate kinase: effects of red cell aging on the activity of two UMPK gene products.An Ashkenazi Jewish woman presenting with favism.Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.Glucose-6-Phosphate Dehydrogenase Deficiency among Male Blood Donors in Sana'a City, YemenA novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro.Inborn errors of metabolism: principles and their applications.Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.Spatial distribution of G6PD deficiency variants across malaria-endemic regions.Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency.Nucleoside deaminase: an enzymatic marker for stress erythropoiesis in the mouse.Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.Decay of a specific NADP(H)-binding protein during aging of normal and glucose 6-phosphate dehydrogenase-deficient erythrocytes.Favism: erythrocyte metabolism during haemolysis and reticulocytosis.Genetic heterogeneity and pathophysiology of G6PD deficiency.Variants of glucose-6-phosphate dehydrogenase.Genetics and clinical enzymology.Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.Mechanism of red blood cell aging: relationship of cell density and cell age.HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects.Erythrocyte Rh antigens increase with red cell age.How do red cell enzymes age? Hypothesis and facts.Kinetic analysis in single, intact cells by microspectrophotometry: evidence for two populations of erythrocytes in an individual heterozygous for glucose-6-phosphate dehydrogenase deficiency.Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy.G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.Glucose-6-phosphate dehydrogenase isoenzymes in blood cells.Inosinate pyrophosphorylase activity in immature blood cells in X-linked congenital hyperuricosuria.In vivo and in vitro variations of human erythrocyte glutathione peroxidase activity as result of cells ageing, selenium availability and peroxide activation.Erythrocyte glucose-6-phosphate dehydrogenase deficiency does not pose an increased risk for black Americans exposed to oxidant gases in the workplace or general environment.
P2860
Q24301040-7C6CC2EC-2740-41B0-9054-BBEB3AFFCC6DQ24675441-4AB24BC1-5610-491D-87F8-402B63469EBEQ28550280-99FA6908-D87A-4F9A-8F01-AC8B5B991212Q33578376-8C052D50-63C7-454B-B026-9701FAD0D1C4Q33717873-97903B3C-F8EC-4D8E-B2EE-F08CD47723E3Q34071076-92033FDA-51ED-40C2-BA0D-DAAB5C6ECEB8Q34302991-B1E2327C-ECB9-42D1-9B3C-9C36D38EB795Q34510044-A3CA0BC7-D8B5-44D1-A159-0C2FED16B386Q34699751-FA1104BB-CF4A-43E2-83B2-E5CF4B500876Q35035895-3AA7B929-2BB2-4010-846D-199D5F3CF286Q35201185-6E715021-E8E1-4772-92CA-07665B115263Q35588396-685897A4-9D42-4120-9E3B-3860D226F0CAQ35682623-0743FEC0-E6EE-4524-8DCF-CD26ACE3E294Q35764492-DD0355AC-0A63-4DFE-80FE-27F3EC959242Q35800621-FDD103B2-B327-4B29-AEBE-6FBF293A270DQ35901876-DE6C9BA1-C9D9-4F51-A08B-9DED0DE4207FQ35926081-9DE79FA1-EEE4-4889-9C58-503089A6DA54Q36762104-9675BF16-29D7-4A97-A705-81B6B0B9AED2Q37329332-5F6167E8-33A8-4AD3-871A-C10D0862D5B2Q37584661-12D9B722-5598-4C31-91A4-13776F944354Q37710661-0FF16108-67BB-4792-BCDA-53A3DAD47F3CQ37737972-592B7423-3EB2-4698-B400-1235850D27A9Q38890746-47867F09-3FFA-4734-87D3-003F7EEAFBCFQ39168682-8069F49D-F9F6-4FB2-9D86-65C69912672DQ39286099-07B17047-F3C9-40BE-91EF-659A02EDD379Q39875147-BE539927-95E7-4B5F-BFC9-06B2D87356D1Q40000599-D63C87BD-BFAD-423D-933A-4F5815652EADQ40007807-704F9FB1-1F39-432C-B117-316E18E639DAQ40326215-A1D767BE-62C2-4B74-8492-15F659FD1FC2Q40867165-E5A9B21E-067B-4810-A881-2ADFC243E2AEQ41235665-8033E859-4961-4497-9A69-1CF6864A6186Q41380756-095D8064-BFD9-45FD-A8E5-964DF7506701Q41476194-3DB15652-A141-4CB1-A417-CEB707F6BEBFQ41477237-CBFA52C4-DECA-479C-815E-5916F0F07071Q42020035-8EEC3EE9-5F31-4188-BB58-B3293F5D4E3BQ43721671-5CB8D41E-55FA-4713-A229-734AF463735CQ44134282-B8075838-F9B9-45AB-AEF4-4B9004E23EC4Q44365921-C5B43097-793D-4930-AE1B-682459045A3AQ45186192-8C779A83-3EAF-4CF4-AAA3-862785E2ED27Q46514778-D5162AC0-0F38-4DC1-8C17-2013407AD411
P2860
In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency.
description
1968 nî lūn-bûn
@nan
1968 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@ast
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@en
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@nl
type
label
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@ast
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@en
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@nl
prefLabel
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@ast
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@en
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@nl
P2093
P2860
P356
P1476
In vivo lability of glucose-6- ...... nd GdMediterranean deficiency.
@en
P2093
Amorosi EL
Davenport DD
Miraglia J
Piomelli S
P2860
P304
P356
10.1172/JCI105786
P407
P577
1968-04-01T00:00:00Z